Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Sinha, Sanjeev ^a   Ekka, Meera ^a   Sharma, Uma ^a   P, Raghunandan ^a   Pandey, R M ^a   Jagannathan, N R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Brain metabolites; Diabetes mellitus; MR Spectroscopy

Indexed keywords

ASPARTIC ACID; CHOLINE; CREATININE; DRUG DERIVATIVE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE; PROTON;

ARTICLE; BRAIN LEVEL; HUMAN; INDIA; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOT STUDY; PROSPECTIVE STUDY; TERTIARY CARE CENTER;

ASPARTIC ACID; BRAIN CHEMISTRY; CHOLINE; CREATININE; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; HUMANS; INDIA; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; PILOT PROJECTS; PROSPECTIVE STUDIES; PROTONS; TERTIARY CARE CENTERS;

EID: 84893088060     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-41     Document Type: Article

References (30)

1. IDF Diabetes Atlas Update 2012 http://www.idf.org/sites/default/files/5E- IDFAtlasPoster-2012-EN.pdf
2. Cognition and synaptic plasticity in diabetes mellitus. Gispen WH, Biessels GJ, Trends Neurosci 2000 23 542 549 10.1016/S0166-2236(00)01656-8 11074263
3. Diabetes and function in different cognitive systems in older individuals without dementia. Arvanitakis Z, Wilson RS, Li Y, Aggarwal NT, Bennett DA, Dia Care 2006 29 560 565 10.2337/diacare.29.03.06.dc05-1901 (Pubitemid 44115354)
4. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Ajilore O, Haroon E, Kumaran S, Darwin C, Binesh N, Mintz J, Miller J, Thomas MA, Kumar A, Neuropsychopharmacology 2006 32 1224 1231 17180124
5. Ageing and diabetes: implications for brain function. Biessels GJ, van der Heide LP, Kamal A, Bleys RLAW, Gispen WH, Eur J Pharmacol 2002 441 1 14 10.1016/S0014-2999(02)01486-3 12007915 (Pubitemid 34465684)
6. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Yau PL, Javier DC, Ryan CM, Tsui WH, Ardekani BA, Ten S, Convit A, Diabetologia 2010 53 2298 2306 10.1007/s00125-010-1857-y 20668831
7. Brain imaging in patients with diabetes: a systematic review. Van Harten B, De Leeuw F-E, Weinstein HC, Scheltens P, Biessels GJ, Diabetes Care 2006 29 2539 2548 10.2337/dc06-1637 17065699 (Pubitemid 44912267)
8. Magnetic resonance spectroscopy of the human brain. Ross B, Bluml S, Anat Rec 2001 265 54 84 10.1002/ar.1058 11323770 (Pubitemid 32281260)
9. Clinical applications of magnetic resonance spectroscopy. Ross B, Michaelis T, Magn Reson Q 1994 10 191 247 7873353
10. Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging. Hsu Y-Y, Chang C, Chang C-N, Chu N-S, Lim K-E, Hsu J-C, Am J Neuroradiol 1999 20 643 651 10319976 (Pubitemid 30429022)
11. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging. Parnetti L, Tarducci R, Presciutti O, Lowenthal DT, Pippi M, Palumbo B, Gobbi G, Pelliccioli GP, Senin U, Mech Ageing Dev 1997 97 9 14 10.1016/S0047-6374(97)01877-0 9223122 (Pubitemid 27279860)
12. Proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD patients: a case control study in north India. Sinha S, Kumar V, Jagannathan NR, Pandey RM, Indian J Chest Dis Allied Sci 2009 51 15 19 19317358
13. Proton magnetic resonance spectroscopy of brain in obstructive sleep apnoea in north Indian Asian subjects. Sharma SK, Sinha S, Danishad KA, Sharma U, Sharma H, Mishra HK, Mishra H, Kadhiravan T, Reddy VV, Sreenivas V, Jagannathan NR, Indian J Med Res 2010 132 278 286 20847374
14. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382
15. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
16. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2010 33 Suppl 1 62 S69 20042775
17. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A, J Diabetes Complications 2008 22 254 260 10.1016/j.jdiacomp.2007.03.007 18413166 (Pubitemid 351885485)
18. Proton MR spectroscopy in clinical routine. Burtscher IM, Holtås S, J Magn Reson Imaging 2001 13 560 567 10.1002/jmri.1079 11276100 (Pubitemid 32231510)
19. Brain metabolic alterations in patients with type 1 diabetes- hyperglycemia-induced injury. Mäkimattila S, Malmberg-Cèder K, Häkkinen A-M, Vuori K, Salonen O, Summanen P, Yki-Järvinen H, Kaste M, Heikkinen S, Lundbom N, Roine RO, J Int Soc Cereb Blood Flow Metab 2004 24 1393 1399 (Pubitemid 40019162)
20. Changes in labile energy metabolites, redox state and intracellular pH in postischemic brain of normo- and hyperglycemic rats. Katsura K, Folbergrová J, Siesjö BK, Brain Res 1996 726 57 63 10.1016/0006-8993(96)00317-4 8836545 (Pubitemid 26292230)
21. Diabetes activates cell death pathway after transient focal cerebral ischemia. Muranyi M, Fujioka M, He Q, Han A, Yong G, Csiszar K, Li P-A, Diabetes 2003 52 481 486 10.2337/diabetes.52.2.481 12540624 (Pubitemid 36173206)
22. MR spectroscopy of cerebral white matter in type 2 diabetes; no association with clinical variables and cognitive performance. Tiehuis A, van der Meer F, Mali W, Pleizier M, Biessels GJ, Kappelle J, Luijten P, Neuroradiology 2010 52 155 161 10.1007/s00234-009-0598-4 19789860
23. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Kreis R, Ross BD, Radiology 1992 184 123 130 1319074
24. Correlation of myo-inositol levels and grading of cerebral astrocytomas. Castillo M, Smith JK, Kwock L, Am J Neuroradiol 2000 21 1645 1649 11039343
25. Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study. Schweinsburg BC, Taylor MJ, Videen JS, Alhassoon OM, Patterson TL, Grant I, Alcohol Clin Exp Res 2000 24 699 705 10.1111/j.1530-0277.2000.tb02042.x 10832912 (Pubitemid 30337766)
26. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Constans JM, Meyerhoff DJ, Gerson J, MacKay S, Norman D, Fein G, Weiner MW, Radiology 1995 197 517 523 7480705
27. Magnetic resonance spectroscopy (MRS): basic principles and applications in focal brain lesions. Sajjad Z, Alam S, Pak J Neurol Sci 2007 2 42 46
28. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Brand A, Richter-Landsberg C, Leibfritz D, Dev Neurosci 1993 15 289 298 10.1159/000111347 7805581 (Pubitemid 24258162)
29. Differentiation of glucose transport in human brain gray and white matter. De Graaf RA, Pan JW, Telang F, Lee JH, Brown P, Novotny EJ, Hetherington HP, Rothman DL, J Int Soc Cereb Blood Flow Metab 2001 21 483 492 (Pubitemid 32422868)
30. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Van de Ven KCC, van der Graaf M, Tack CJ, Heerschap A, De Galan BE, Diabetes 2012 61 1974 1977 10.2337/db11-1778